Assenagon Asset Management S.A. Biogen Inc. Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Biogen Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 43,349 shares of BIIB stock, worth $6.64 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

43,349

Previous 42,737 1.43%

Holding current value

$6.64 Million

Previous $9.91 Million 15.19%

% of portfolio

0.02%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$189.07 - $236.8 $115,710 - $144,921	612 Added 1.43%	43,349 $8.4 Million
Q2 2024 Jul 18, 2024	SELL	$190.52 - $236.72 $19,433 - $24,145	-102 Reduced 0.24%	42,737 $9.91 Million
Q1 2024 Apr 24, 2024	SELL	$212.02 - $267.71 $79,931 - $100,926	-377 Reduced 0.87%	42,839 $9.24 Million
Q4 2023 Jan 17, 2024	SELL	$222.59 - $267.94 $19.3 Million - $23.2 Million	-86,525 Reduced 66.69%	43,216 $11.2 Million
Q3 2023 Nov 06, 2023	SELL	$253.3 - $285.89 $22 Million - $24.9 Million	-86,935 Reduced 40.12%	129,741 $33.3 Million
Q2 2023 Jul 25, 2023	SELL	$275.25 - $318.06 $38.2 Million - $44.2 Million	-138,859 Reduced 39.06%	216,676 $61.7 Million
Q1 2023 Apr 18, 2023	SELL	$256.56 - $292.34 $45.1 Million - $51.4 Million	-175,877 Reduced 33.1%	355,535 $98.8 Million
Q4 2022 Jan 12, 2023	SELL	$252.44 - $306.72 $18.1 Million - $22 Million	-71,804 Reduced 11.9%	531,412 $147 Million
Q3 2022 Oct 27, 2022	SELL	$194.69 - $268.46 $6.98 Million - $9.62 Million	-35,841 Reduced 5.61%	603,216 $161 Million
Q2 2022 Jul 27, 2022	BUY	$187.54 - $223.02 $16.2 Million - $19.3 Million	86,578 Added 15.67%	639,057 $130 Million
Q1 2022 Apr 25, 2022	BUY	$193.77 - $244.14 $40 Million - $50.3 Million	206,210 Added 59.55%	552,479 $116 Million
Q4 2021 Feb 01, 2022	SELL	$223.92 - $287.77 $90.7 Million - $117 Million	-405,120 Reduced 53.92%	346,269 $83.1 Million
Q3 2021 Oct 19, 2021	BUY	$282.99 - $369.05 $113 Million - $147 Million	399,310 Added 113.41%	751,389 $213 Million
Q2 2021 Jul 15, 2021	BUY	$259.0 - $414.71 $22.8 Million - $36.5 Million	88,059 Added 33.35%	352,079 $122 Million
Q1 2021 Apr 26, 2021	BUY	$242.95 - $284.63 $3.2 Million - $3.75 Million	13,174 Added 5.25%	264,020 $73.9 Million
Q4 2020 Feb 01, 2021	BUY	$236.26 - $355.63 $27.7 Million - $41.7 Million	117,207 Added 87.7%	250,846 $61.4 Million
Q3 2020 Oct 07, 2020	SELL	$264.77 - $305.71 $51.2 Million - $59.1 Million	-193,256 Reduced 59.12%	133,639 $37.9 Million
Q2 2020 Jul 21, 2020	BUY	$258.66 - $342.55 $50.5 Million - $66.8 Million	195,146 Added 148.12%	326,895 $87.5 Million
Q1 2020 Apr 17, 2020	SELL	$268.85 - $341.04 $92.8 Million - $118 Million	-345,092 Reduced 72.37%	131,749 $41.7 Million
Q4 2019 Jan 17, 2020	SELL	$220.06 - $304.07 $43.6 Million - $60.2 Million	-198,091 Reduced 29.35%	476,841 $141 Million
Q3 2019 Oct 16, 2019	BUY	$217.44 - $243.88 $137 Million - $153 Million	628,233 Added 1345.28%	674,932 $157 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $60 Million - $66.2 Million	-273,741 Reduced 85.43%	46,699 $10.9 Million
Q1 2019 Apr 26, 2019	BUY	$216.71 - $338.96 $13.4 Million - $20.9 Million	61,640 Added 23.82%	320,440 $75.7 Million
Q4 2018 Jan 23, 2019	BUY	$278.5 - $352.75 $13 Million - $16.4 Million	46,593 Added 21.96%	258,800 $77.9 Million
Q3 2018 Oct 29, 2018	SELL	$293.51 - $383.83 $12.2 Million - $15.9 Million	-41,473 Reduced 16.35%	212,207 $75 Million
Q2 2018 Jul 17, 2018	BUY	$257.52 - $306.91 $25.7 Million - $30.7 Million	99,946 Added 65.01%	253,680 $73.6 Million
Q1 2018 Apr 30, 2018	BUY	$260.13 - $367.91 $15.8 Million - $22.3 Million	60,616 Added 65.1%	153,734 $42.1 Million
Q4 2017 Jan 25, 2018	SELL	$307.64 - $344.58 $92.7 Million - $104 Million	-301,279 Reduced 76.39%	93,118 $29.7 Million
Q3 2017 Oct 18, 2017	BUY	$281.15 - $329.69 $111 Million - $130 Million	394,397	394,397 $123 Million

Others Institutions Holding BIIB

# of Institutions

1,035

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Biogen Inc. Transaction History